Vancomycin-resistant enterococcus (VRE) are increasingly important pathogens in stem cell transplant (SCT). In all, 61 pediatric SCT patients had surveillance stool cultures for VRE between July 1999 ...
Researchers have developed a novel combination therapy using an anticancer agent, mitoxantrone (MTX), together with an antibiotic, vancomycin, for treating bacteria that are resistant to the ...
Vancomycin-resistant enterococcus (VRE) is among the leading causes of hospital-acquired infections in the United States. An estimated 20,000 people in the U.S. become infected with it each year, and ...
WEST LAFAYETTE, Ind. – Vancomycin-resistant enterococcus (VRE) is among the leading causes of hospital-acquired infections in the United States. An estimated 20,000 people in the U.S. become infected ...
Please provide your email address to receive an email when new articles are posted on . The array of health care-associated infections, ranging from catheter-associated UTIs to Clostridioides ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Stopping contact precautions for MRSA and ...
Antibiotic exposure and dirty hands were factors linked to nursing home contamination with the multidrug-resistant bacteria vancomycin-resistant Enterococci, or VRE, a new study finds. The report was ...
Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity against drug-resistant bacterial pathogens, including MRSA and VRE ...
Antibiotic resistance is one of the most urgent threats to global health, linked to an estimated 4.7 million deaths worldwide in 2019 alone. As more bacteria evolve to evade even last-resort drugs, ...
Morning Overview on MSN
Scientists found a hidden antibiotic 100 times stronger than today’s drugs against superbugs
Researchers at the University of Warwick have identified a set of antibiotic compounds hidden inside a well-studied soil ...
Researchers have developed small molecules to combat deadly, drug-resistant enterococcus. Vancomycin-resistant enterococcus (VRE) is among the leading causes of hospital-acquired infections in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results